(Washington, D.C.) – Thousands of walkers, runners, volunteers, activists and survivors will gather in Washington, D.C. on Sunday, May 7, 2017 for the world’s largest brain tumor community event: the 20th annual Race for Hope – DC, presented by Cushman & Wakefield. Since its inception in 1998, the annual race has united more than 100,000 attendees and raised more than $28 million for brain tumor research and advocacy. American Idol® winner David Cook returns as Honorary Chair.
The Race for Hope - DC has grown to more than 10,000 participants over a weekend of activities benefiting ABC² (Accelerate Brain Cancer Cure) and the National Brain Tumor Society. Both organizations share a common goal: a day when there is a cure, and when all patients with brain tumors are told they have a manageable disease. Race for Hope – DC is the nation’s flagship fundraising event for brain tumor research. This year’s race includes more than 450 fundraising teams and aims to raise nearly $2 million.
Each year, Race for Hope – DC helps to bring hope and attention to the often underserved brain tumor community. The need to increase research funding is more urgent than ever – today, nearly 700,000 Americans are living with a primary brain tumor diagnosis, and within the next 12 months, more than 210,000 more will be diagnosed with a primary or metastatic brain tumor.
Singer-songwriter and American Idol® winner David Cook will return for the ninth year as Honorary Chair of the event. A vocal brain cancer research advocate, Cook and his fans have raised more than $1.2 million for research and he has spoken publicly about his brother, Adam, who lost his valiant battle with brain cancer in 2009. This year, Cook returns to the Race for Hope – DC to remember his brother and send a message of hope and resilience to the families of nearly 700,000 people living with a primary brain tumor diagnosis in the United States.
“The Race for Hope is always such an amazing experience and I’m proud to be part of an event that brings together people who all share a common goal: an end to brain cancer,” said Cook. “We honor the memories of those who have lost their battle with brain tumors, and celebrate the survivors and family members who continue to fight the disease.” As part of his support for the race Cook will play a “Total Request” concert on May 5th at Jammin Java in Vienna, Virginia to kick off the weekend’s events.
Tickets for the concert are $40 at http://www.jamminjava.com/event/1451540-david-cook-dctr-david-cook-vienna/
Highlights of the 20th annual Race for Hope-DC include: a Survivor Tribute featuring more than 350 brain tumor survivors who will march together towards the start line as a symbol of hope and strength in their battle against brain tumors; a kids’ Fun Run and the Rabbi Joseph Weinberg Triumph of the Spirit Award honoring the Roth Family and Urban Country Design for creating the Wall of Hope – a 24 foot long tribute to brain tumor survivors and those who lost their battles.
The Race begins at Freedom Plaza at 13th Street and Pennsylvania Avenue (metro accessible) at 9:00 a.m. on Sunday, May 7th, 2017. Sponsors include: Cushman & Wakefield, HFF/The Conley Family, Cravath, Swaine & Moore, LLP, R&R Mechanical, Genentech, M&T Bank, Normandy Real Estate Partners, the Case Foundation, and Newmark Grubb Knight Frank.
Online registration for the race concludes Sunday, April 30, 2017. To register as a participant or volunteer visit www.curebraintumors.org
About ABC² (Accelerate Brain Cancer Cure)
ABC² is focused on speeding the discovery of a cure for brain cancer. By applying an aggressive, venture funding approach not typically seen in the nonprofit sector, ABC2 closes current gaps in funding in order to catalyze research and rapidly bring new therapies to patients. ABC2 has awarded more than 100 grants totaling $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 54 institutions and companies. To learn more, visit www.abc2.org.
About National Brain Tumor Society
National Brain Tumor Society is the largest nonprofit organization dedicated to the brain tumor community in the United States. We are strategically positioned at key junctions in the drug development pipeline to leverage our collective resources and knowledge for greatest impact. From catalytic funding to intensive research collaborations to advocating for policies that impact those affected, we’re ensuring change on every level. To learn more visit www.braintumor.org